3 ms·
I don't think if the question is whether large bills can be handled by distributing $1M payments over N years. The question is, should this really be costing $1
by sytelus 8y ago
I don't think if the question is whether large bills can be handled by distributing $1M payments over N years. The question is, should this really be costing $1M? I understand if there is a billion dollar investment by big pharma that benefits 1000 people and so there is no other way but to charge $1M. However, it appears that fundamental techniques are all same and it gets reused for hundreds or thousands different treatments. So with cost spread, the cost to patient shouldn't be $1M. If big pharma has life saving treatment and they thought they got people by their balls to pay up any ransom amount then its just wrong.
- refurb 8y agoFor many of these diseases, yes there are only a a few thousand patients in the world. And although gene therapy might be a fundamental technique, creating a gene therapy for a different disease is really hard because human biology is really hard.